AU3411399A - Sucrose-n-alkyl-asparaginates, production and use thereof - Google Patents
Sucrose-n-alkyl-asparaginates, production and use thereof Download PDFInfo
- Publication number
- AU3411399A AU3411399A AU34113/99A AU3411399A AU3411399A AU 3411399 A AU3411399 A AU 3411399A AU 34113/99 A AU34113/99 A AU 34113/99A AU 3411399 A AU3411399 A AU 3411399A AU 3411399 A AU3411399 A AU 3411399A
- Authority
- AU
- Australia
- Prior art keywords
- sucrose
- alkylaspartate
- formula
- radical
- pct
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title description 4
- 229930006000 Sucrose Natural products 0.000 claims description 69
- 239000005720 sucrose Substances 0.000 claims description 69
- 150000001875 compounds Chemical class 0.000 claims description 65
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 64
- 239000000203 mixture Substances 0.000 claims description 50
- -1 basic metal salt Chemical class 0.000 claims description 43
- 238000000034 method Methods 0.000 claims description 34
- 230000008569 process Effects 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 238000006243 chemical reaction Methods 0.000 claims description 27
- 150000003254 radicals Chemical class 0.000 claims description 27
- 239000004094 surface-active agent Substances 0.000 claims description 23
- 239000003599 detergent Substances 0.000 claims description 20
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 14
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 14
- 150000001412 amines Chemical class 0.000 claims description 12
- 239000011734 sodium Substances 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 11
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Chemical group CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims description 10
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 10
- 238000006467 substitution reaction Methods 0.000 claims description 10
- 239000003925 fat Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 239000002453 shampoo Substances 0.000 claims description 8
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 7
- 244000060011 Cocos nucifera Species 0.000 claims description 7
- 239000000654 additive Substances 0.000 claims description 7
- 239000002537 cosmetic Substances 0.000 claims description 7
- 238000004851 dishwashing Methods 0.000 claims description 7
- 235000013305 food Nutrition 0.000 claims description 7
- 239000003788 bath preparation Substances 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 239000000344 soap Substances 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 239000004064 cosurfactant Substances 0.000 claims description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 238000009991 scouring Methods 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 4
- 229910052728 basic metal Inorganic materials 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 239000003760 tallow Substances 0.000 claims description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 238000011109 contamination Methods 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 229930182470 glycoside Natural products 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 239000012096 transfection reagent Substances 0.000 claims description 3
- 241001133760 Acoelorraphe Species 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 2
- 229910001413 alkali metal ion Inorganic materials 0.000 claims description 2
- 229910001420 alkaline earth metal ion Inorganic materials 0.000 claims description 2
- 239000003778 fat substitute Substances 0.000 claims description 2
- 235000013341 fat substitute Nutrition 0.000 claims description 2
- 229910052744 lithium Inorganic materials 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 239000011976 maleic acid Substances 0.000 claims description 2
- 239000000575 pesticide Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 238000006277 sulfonation reaction Methods 0.000 claims description 2
- 239000008186 active pharmaceutical agent Substances 0.000 claims 4
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 150000002689 maleic acids Chemical class 0.000 claims 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- MDLWEBWGXACWGE-UHFFFAOYSA-N octadecane Chemical group [CH2]CCCCCCCCCCCCCCCCC MDLWEBWGXACWGE-UHFFFAOYSA-N 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 60
- 239000000047 product Substances 0.000 description 35
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 33
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 29
- 230000002829 reductive effect Effects 0.000 description 24
- 239000002904 solvent Substances 0.000 description 22
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 20
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 18
- 238000003756 stirring Methods 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 17
- 239000007787 solid Substances 0.000 description 17
- 239000006260 foam Substances 0.000 description 14
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 13
- 238000007792 addition Methods 0.000 description 13
- 239000001632 sodium acetate Substances 0.000 description 13
- 235000017281 sodium acetate Nutrition 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 238000009472 formulation Methods 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 11
- 239000004480 active ingredient Substances 0.000 description 10
- 238000005187 foaming Methods 0.000 description 9
- 229910000029 sodium carbonate Inorganic materials 0.000 description 9
- 235000017550 sodium carbonate Nutrition 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 239000013543 active substance Substances 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 238000005160 1H NMR spectroscopy Methods 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 230000010933 acylation Effects 0.000 description 6
- 238000005917 acylation reaction Methods 0.000 description 6
- 150000007942 carboxylates Chemical group 0.000 description 6
- 239000007795 chemical reaction product Substances 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 230000010354 integration Effects 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 6
- 229910001415 sodium ion Inorganic materials 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 150000003973 alkyl amines Chemical class 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 238000000921 elemental analysis Methods 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- AOHAPDDBNAPPIN-UHFFFAOYSA-N myristicinic acid Natural products COC1=CC(C(O)=O)=CC2=C1OCO2 AOHAPDDBNAPPIN-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 238000007127 saponification reaction Methods 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- HZRZJJCJRNJMCL-AWEZNQCLSA-N (2s)-2-(dodecylamino)butanedioic acid Chemical compound CCCCCCCCCCCCN[C@H](C(O)=O)CC(O)=O HZRZJJCJRNJMCL-AWEZNQCLSA-N 0.000 description 3
- KZMAWJRXKGLWGS-UHFFFAOYSA-N 2-chloro-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-n-(3-methoxypropyl)acetamide Chemical compound S1C(N(C(=O)CCl)CCCOC)=NC(C=2C=CC(OC)=CC=2)=C1 KZMAWJRXKGLWGS-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- NHXXLZBKTKNTEF-UHFFFAOYSA-N chembl1997306 Chemical compound CC1=CC=CC(N=NC=2C(=CC(=CC=2)N=NC=2C3=CC=CC=C3C=CC=2O)C)=C1 NHXXLZBKTKNTEF-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- LMXOWXVJZDTLAD-UHFFFAOYSA-N dodecan-1-amine Chemical compound CCCCCCCCCCCCN.CCCCCCCCCCCCN LMXOWXVJZDTLAD-UHFFFAOYSA-N 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 3
- 239000003973 paint Substances 0.000 description 3
- 235000019613 sensory perceptions of taste Nutrition 0.000 description 3
- 230000035923 taste sensation Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- 0 *C(CC(OC[C@](C(C1O)O)O[C@@]1(CO)O[C@](C(C1O)O)OC(COC(CC(C(O)=O)N*)=O)[C@]1O)=O)C(O)=O Chemical compound *C(CC(OC[C@](C(C1O)O)O[C@@]1(CO)O[C@](C(C1O)O)OC(COC(CC(C(O)=O)N*)=O)[C@]1O)=O)C(O)=O 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N Behenic acid Natural products CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical group C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical class CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 239000004280 Sodium formate Substances 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 150000002688 maleic acid derivatives Chemical class 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 150000002888 oleic acid derivatives Chemical class 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000011814 protection agent Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000001177 retroviral effect Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 2
- 235000019254 sodium formate Nutrition 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000003445 sucroses Chemical class 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- UDYFLDICVHJSOY-UHFFFAOYSA-N sulfur trioxide pyridine complex Chemical compound O=S(=O)=O.C1=CC=NC=C1 UDYFLDICVHJSOY-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 description 1
- FJLUATLTXUNBOT-UHFFFAOYSA-N 1-Hexadecylamine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 1
- GYSCBCSGKXNZRH-UHFFFAOYSA-N 1-benzothiophene-2-carboxamide Chemical compound C1=CC=C2SC(C(=O)N)=CC2=C1 GYSCBCSGKXNZRH-UHFFFAOYSA-N 0.000 description 1
- RSMRWWHFJMENJH-LQDDAWAPSA-M 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium;methyl sulfate Chemical compound COS([O-])(=O)=O.CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC RSMRWWHFJMENJH-LQDDAWAPSA-M 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- KWZAXBZEPADBLS-UHFFFAOYSA-N 2-[2-[[[2-(4-bromothiophen-2-yl)-2-hydroxyethyl]amino]methyl]phenoxy]-n-ethylacetamide Chemical compound CCNC(=O)COC1=CC=CC=C1CNCC(O)C1=CC(Br)=CS1 KWZAXBZEPADBLS-UHFFFAOYSA-N 0.000 description 1
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 1
- ADLSFYJDHWUKFP-UHFFFAOYSA-N 5-methoxy-11,12-dihydroindolo[2,3-a]carbazole-6-carbonitrile Chemical compound N1C2=C3NC4=CC=C[CH]C4=C3C(OC)=C(C#N)C2=C2[C]1C=CC=C2 ADLSFYJDHWUKFP-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 229930183010 Amphotericin Natural products 0.000 description 1
- QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 description 1
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 229930105110 Cyclosporin A Natural products 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N Decanoic acid Natural products CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 241001484259 Lacuna Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical class ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- ISXSJGHXHUZXNF-LXZPIJOJSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] n-[2-(dimethylamino)ethyl]carbamate;hydrochloride Chemical compound Cl.C1C=C2C[C@@H](OC(=O)NCCN(C)C)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 ISXSJGHXHUZXNF-LXZPIJOJSA-N 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 239000000061 acid fraction Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 1
- 229960000250 adipic acid Drugs 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940009444 amphotericin Drugs 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 150000001509 aspartic acid derivatives Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- 239000003876 biosurfactant Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 235000019879 cocoa butter substitute Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- FFYWKOUKJFCBAM-UHFFFAOYSA-N ethenyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC=C FFYWKOUKJFCBAM-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000003977 halocarboxylic acids Chemical class 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 238000009897 hydrogen peroxide bleaching Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000010705 motor oil Substances 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000008105 phosphatidylcholines Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920005646 polycarboxylate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- DNXIASIHZYFFRO-UHFFFAOYSA-N pyrazoline Chemical class C1CN=NC1 DNXIASIHZYFFRO-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003335 secondary amines Chemical group 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960001922 sodium perborate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- FRPJTGXMTIIFIT-UHFFFAOYSA-N tetraacetylethylenediamine Chemical compound CC(=O)C(N)(C(C)=O)C(N)(C(C)=O)C(C)=O FRPJTGXMTIIFIT-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000007332 vesicle formation Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/30—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests characterised by the surfactants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/02—Anionic compounds
- C11D1/04—Carboxylic acids or salts thereof
- C11D1/10—Amino carboxylic acids; Imino carboxylic acids; Fatty acid condensates thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/02—Anionic compounds
- C11D1/12—Sulfonic acids or sulfuric acid esters; Salts thereof
- C11D1/26—Sulfonic acids or sulfuric acid esters; Salts thereof derived from heterocyclic compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Dentistry (AREA)
- Pest Control & Pesticides (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Saccharide Compounds (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Edible Oils And Fats (AREA)
- Medicinal Preparation (AREA)
Description
WO 99/48901 PCT/EP99/01619 2 process, the fatty acid ester is dispersed in a solution of the carbohydrate with the help of an emulsifier. The solvent is removed before the actual esterification takes places (EP 0254376). In the solvent-free process, the so-called direct process, the fatty acid methyl ester is reacted in the melt with sucrose and a basic catalyst (GB 1399053). In another process, lipases are used (DE 3430944). Finally, the esterification of sucrose can also be carried out with carbonyl chlorides or carboxylic anhydrides. In processes which are less suitable for industrial productions, expensive auxiliary bases, such as, for example, pyridine or N,N dimethylaminopyridine, are required for this (DE 19542303). In the last mentioned laid-open specification, mixtures of oxidized sucroses, in particular of sucrose monocarboxylic acids are used, which for their part can be prepared in a complex oxidation process in low yield, e.g. as in DE 4307388. The known transesterification processes are very complex both with regard to carrying out the process and also isolation of the product. The reaction parameters pressure and temperature have to be carefully controlled and, to isolate the sucrose ester, repeated extraction and distillation are required. In addition, the high reaction temperatures, in combination with the long reaction times, lead to discoloration of the products, which can only be reversed again by means of complex purification procedures. A further disadvantage of the compounds according to Fig. 2 is that although, as monoesters or as diesters, they exhibit surface-active properties, they can only be used as surfactants to a restricted extent because of their limited solubility in water. The monoesters dissolve sparingly in cold water, while the diesters are only emulsifiable in water. The multistage process mentioned in DE 19542303 attempts therefore to circumvent these problems by oxidatively introducing the additional carboxylate group in the sucrose molecule. In EP 0324595 "aminofunctional compounds as builders/dispersants in cleaners" are described, which are obtained by addition of amino acids to maleate half-esters or polyols. The latter are obtained by reacting maleic anhydride, in particular with polyvinyl alcohol, sucrose also being cited. Although the reaction of maleic anhydride with alcohols has been known for a long time, the subsequent reaction with amino acids is problematical since it requires a balance system of buffers and bases which suppresses WO 99/48901 PCT/EP99/01619 3 the alkaline back-reaction of the maleate half-ester. NaOH/Na 2 CO3 is preferably added for this purpose. The excess bases have to be neutralized and the salts separated off as byproducts. Furthermore, complete purification steps are required and the yields are not quantitative since the maleate half-ester is of course cleaved off again with aqueous alkali metal hydroxides as a result of hydrolysis. The maleate half-ester of sucrose according to Fig. 3 is described for example, as a builder (CO-/builder) in detergents (DE 2148279). In DE 2739343 "basic" surface-active esters of aliphatic polyols are described, it also being possible to use sucrose as the polyhydroxy compound. Given as an acid component are compounds of the formula
R
8
-N(R
9 )-CH(R1 0 )-CH(R11)-COOH, where R8 can be a C 8
-C
2 2-alkyl or alkenyl radical, R9 and R11 can, inter alia, also be hydrogen, and R10 can, inter alia, also be a carboxyl group. However, "acidic esters" of this type can not be prepared by the multi-stage process described in DE 2739343 because according to this only "basic esters" of sucrose are accessible, i.e. completely esterified carboxylates in which the carboxyl group (radical R10) is also present in esterified form, and not in protonated or anionic form. The object of the present invention was therefore to provide novel derivatives of sucrose which can be prepared easily and can be used as surface-active compounds. Surprisingly, "acidic esters" of sucrose have the required properties. The present invention therefore provides sucrose N-alkylaspartates of the formula (1) OR,
R
1 0 R1 R10 RIO 0 ,%#-OR RIO R10 WO 99/48901 PCT/EP99/01619 4 in which R 1 independently of one another, identically or different is a group chosen from hydrogen, a compound of the formula (11): 0 O M
HN-R
2 (11) where R2 is CnH2n+1 or CnH2n, in which n is an integer from 2 to 28, preferably 6-22, especially 12-18, a compound of the formula (lli) and/or a radical of the formula (IV) O=S-O M (IV) and M is hydrogen, an alkali metal ion and/or an alkaline earth metal ion, preferably a sodium, potassium, lithium, magnesium, calcium and/or ammonium ion, with the proviso that at least one radical R is a compound of the formula (1l). The compounds of the formula (I) according to the invention cannot be prepared by the process described in DE 2739343 because for this, in an additional synthesis step, a chemoselective abstraction of the ester group designated by R10 has to be carried out. This is not, however, possible using known methods since in this case the ester bond just linked via the other carboxyl group in R 8 -N(Rg)-CH(R 10 )-CH(R11)-COOH, would simultaneously be split back again. This hydrolysis occurs even at a mild pH below pH=10. In addition, the "basic esters" in DE 2739343 are WO 99/48901 PCT/EP99/01619 5 described as clearly water-soluble, resin-like and low-foaming or virtually non-foaming. By contrast, the "acidic esters" of the formula (1) according to the invention are partially crystalline but amorphous solids having only limited water solubility, forming very stable, high-foaming emulsions. This is particularly surprising because aliphatic esters of carboxylic acids are generally less soluble in water than their salts. Moreover, from the stoichiometry of the reactions described in the examples of DE 2739343 it is possible to conclude that the "basic esters" described are mixtures of sucrose with the reaction components of the formula R 8 -N(Rg)-CH(R1o)-CH(R11)-CO2CH3, For example, in Example 6 of DE 2739343, 137 parts of sucrose were reacted with 66 parts of a compound of the empirical formula C 12
H
25
NH
CH(COOCH3)(CH2COOCH3). Purely theoretically, this reaction could have only led to 128 parts of the product. In actual fact, however, 189 parts of product were obtained. The difference can only be unreacted sucrose, which is clearly water-soluble and does not have a foaming action in water. In actual fact, also only a content of basic nitrogen of 1.4% was found, which would also have been expected if the substances had been merely mixed together (calculated 1.4%). However, the predicted reaction products would have had a theoretical nitrogen content of 2.2%. Also, the value of 123, given as the saponification number does not permit inference to the formation of a reaction product because, from the stoichiometry, no change in the saponification number can be expected, and because, from the 66 parts of the compound C1 2
H
2 5NH-CH(COOCH3)(CH2COOCH3) having the theoretical saponification number 122 used, in each case virtually the same saponification number must again be found. From this is drawn the conclusion that the reactions in DE 2739343 can not lead to the "acidic esters" according to the invention, does not describe a preparation, and thus does not represent prior art in this respect. The present invention therefore provides new types of sucrose N alkylaspartate of the formula (1) which can be prepared surprisingly easily in high yields in a two-stage one-part process, and can be used as readily biodegradable, physiologically compatible and surface-active substances having a broad use. The compounds according to the invention are notable for the fact that at least one and up to eight radicals R 1 represents a 3- WO 99/48901 PCT/EP99/01619 6 alkylamino-substituted half-ester radical of 1,4-butanedicarboxylic acid or salts thereof according to the formula (II). To regulate the solubility of properties the compounds according to the invention can, in a preferred embodiment, also comprise one or more maleate radicals of the formula (Ill), in particular in accordance with the definition, given in Fig. 1, of the degree of substitution DS, which also includes fractions, where the total of the radicals I and Ill does not exceed the value DS = 8. In metal-free form (M = H ), the compounds according to the invention as is typical in the case of amino acids - can also be in the form of internal salts (betaines) with protonation of the amino function. M is preferably an ion of the alkali metal and alkaline earth metals such as Na , K , Li 2+ 2+ E Mg , Ca and NH 4 , particularly preferably sodium or potassium ions, or mixtures thereof. Suitable alkylamino radicals NHR originate from primary amines (monoalkylamines R 2NH2) of chain lengths C2 to C28, preferably from commercially available fatty amines having chain lengths from C6 to C22, in particular from C12 to C18, which are obtained from varyingly broad production cuts, including hydrogenated ones, for example from coconut, from palm, soya or tallow oil fats, especially from decyl-, dodecyl-, tetradecyl-, hexadecyl or octadecylamines or from radicals which are derived from coconut, palm, soya or tallow oil fat. Accordingly, the compounds according to the invention can also carry different radicals. Coconut fat generally comprises a mixture of hexanoic, octanoic, decanoic, lauric, myristic, palmitic, stearic, behenic, oleic and linoleic acid radicals. Palm oil generally comprises a mixture of myristic, palmitic, stearic, oleic and linoleic acid radicals. Soya oil comprises, inter alia, radicals having a carbon chain length of 14, 16, 18, 20 and 22 carbon atoms, where, usually, C14 is unsaturated, C16 is monounsaturated and saturated, C18 is mono-, di- and triunsaturated and saturated, C20 is monounsaturated and saturated, and C22 is saturated. Tallow fat generally comprises radicals having 14, 16 and 18 carbon atoms.
WO 99/48901 PCT/EP99/01619 7 In a further preferred embodiment, one or more, preferably up to 2 radicals R can also be in sulfated form, where the sum of the radicals 11, Ill and IV cannot of course exceed the numeral 8. The present invention further provides a process for the preparation of a sucrose N-alkylaspartate of the formula (I), where, in a first step, sucrose is acylated with maleic acid or a derivative of maleic acid, and in a second step, one to eight mole equivalents of amine of formula R 2NH2, where R2 is CnH2n+1, in which n is an integer from 2 to 28, preferably 6 to 22, especially 12 to 18, is added to the maleate sucrose formed in the first step. The process according to the invention consists in the acylation of the sucrose with, preferably, maleic anhydride (MA) and the subsequent addition of fatty amines to the CC double bond of the intermediate maleate sucrose, preferably without isolation or purification of the intermediate. Another suitable acylating agent is maleoyl chloride. The fatty acid radical is not introduced directly as a result of acylation of the OH groups of sucrose, but indirectly via the addition of the fatty amines to the intermediate, which is preferably not isolated. This forms an N-alkylated aspartic acid, which acts as a linker group for the lipophilic alkyl radical. Both partial steps proceed largely stoichiometrically within the meaning of additions without the formation of stoichiometric amounts of salt as byproducts. In a preferred embodiment, the acylation is carried out in the presence of a catalyst, preferably in the presence of a basic metal salt, in particular a carbonate, hydrogencarbonate, acetate and/or formate. Usually, one equivalent of a basic metal salt is consumed, which acts as a catalyst in the acylation with MA, and for the neutralization of the carboxylate formed. Depending on the metal salt, byproducts are the readily removable acetic acid or carbon dioxide. At the same time, the formation of the carboxylate salt prevents, in an advantageous manner, the consumption of a salt bonded fatty amine equivalent, which is then no longer available for the subsequent addition to the CC double bond. The carboxylate group formed in the first partial step additionally brings about an improvement in the hydrophilic properties and the water solubility of the surface-active substances. Surprisingly, the process manages entirely without additions of WO 99/48901 PCT/EP99/01619 8 aqueous bases and buffer systems, for example as described in the application EP 0324595, which is therefore particularly advantageous. In a further embodiment of the process according to the invention, the sucrose N-alkylaspartate are sulfonated, where, preferably, up to two radicals R are sulfonated by one of the methods for the functionalization of hydroxyl and amino groups which are known to the person skilled in the art. For this, following the above-described reactions, the reaction products are reacted in the same reaction vessel or following removal of the intermediates, with the calculated amount of a sulfonation reagent, optionally following the addition of an inert solvent, such as, for example, dichloromethane, tetrahydrofuran or dioxane. Suitable sulfonating reagents are, for example, S03, CISO 3 H, DMF-SO3 and/or pyridine-S03 The advantages of the process according to the invention compared with the known preparation processes are the high reactivity of the maleic anhydride and the nucleophilic attack of the fatty amine on the electrophilic CC double bond, as a result of which, for this reaction step, it is possible to dispense with further purification steps, expensive auxiliary bases or auxiliary reagents, such as, for example, catalysts. Through appropriate choice of the radicals R and the degree of substitution DS, the process further permits the provision of a high number of differently substituted compounds according to formula (1) having tailored use properties and fields of use. In addition, the yields in the two-stage one-part process are greater than 90%. The process according to the invention for the preparation of compounds according to formula (1) having a defined DS can, for example, be carried out as follows: Sucrose and the appropriately calculated amount of, for example, maleic anhydride and an amount, equivalent, for example, for this purpose, of a basic metal salt (MX), such as, for example, sodium hydrogencarbonate, sodium carbonate, sodium acetate, sodium formate, lithium acetate or potassium acetate, preferably sodium hydrogencarbonate, sodium carbonate or sodium acetate, is reacted without a diluent or in a suitable solvent, for example in N,N-dimethylformamide (DMF), N,N dimethylacetamide (DMA), dioxane, N-methylpyrrolidone (NMP), DMSO, WO 99/48901 PCT/EP99/01619 9 tetrahydrofuron (THF), or in mixtures of these solvents, preferably in N,N dimethylformamide, N-methylpyrrolidone, DMSO, dioxane or in mixtures of these solvents, at temperatures of 20 0 C up to the boiling point of the solvent in question or of the solvent mixture in question, preferably at temperatures in the range from about 20 to about 140 0 C, in particular at temperatures from about 40 to about 120 0 C. The reaction is complete when consumption of the sucrose is complete, which is readily detectable using thin layer chromatography. Then, the amount, calculated according to the desired DS, of the alkylamine R 2NH2 in question or of the alkylamine mixture is added, and the mixture is stirred in the same reaction vessel at temperatures of about 0 0 C to the boiling point of the solvent or of the solvent mixture in question, preferably at temperatures from about 20 to about 60 0 C, until the reaction is, according to thin-layer chromatographic analysis, complete. During the reaction, some of the end product precipitated out as a colorless solid, which can be filtered off with suction, washed and dried. The majority of the solvent used is preferably distilled off, and the product is isolated by stirring with a low-boiling solvent. Alternatively, the product can also be precipitated out of the reaction solution by addition of the corresponding amount of solvent. Suitable solvents for the stirring-out and the precipitation process are ethyl acetate, hexane, methyl isobutyl ketone, acetone and the like. The solid end product is obtained following thorough vacuum drying as a colorless, odorless powder. Depending on the nature of the metal salt MX used, the process gives the corresponding carboxylate salt as the end product, preference being given to the sodium or potassium salts or mixtures thereof. These can also be converted, using equivalent amounts of proton acids, into the free carboxylic acids (M = H ), which, because of the secondary amine function present, are in equilibrium with the betaine form. By the careful addition of at most one further acid equivalent, the secondary amino group in the aspartic acid fraction can also be protonated, it being possible, for example, to use halocarboxylic acids, aliphatic and aromatic dicarboxylic acids and sulfonic acids. The negative counterion used has an effect, for example, on the surfactant properties of the compound according to the invention. As a result of suitable choice of the counterion, for example a WO 99/48901 PCT/EP99/01619 10 paraffin sulfonate, it is thus possible, for example, to prepare tailored thickeners in formulations for shampoos and other cosmetic cleaners, and for liquid surfactant systems. In a further embodiment, following the reaction described above, the products obtained are reacted, in the same reaction vessel or following removal of the intermediates, with the corresponding amount of the sulfonating reagent (preferably up to two mol equivalents of the sulfonating reagent, optionally with the addition of an inert solvent, such as, for example, dichloromethane, tetrahydrofuran or dioxane. Preferred sulfonating reagents are, for example, SO3, CISO3H, DMF-SO3 or pyridine-S03. The compounds of the formula (1) obtained by the process according to the invention are characterized by means of analytical and spectroscopic methods, such as TLC, 1 H-NMR and mass (spectroscopy), and elemental analysis. The DS of the products can be determined using the proton ratio (integration of the 1 H-NMR signals) and by means of elemental analysis. The compounds according to the invention have excellent surface-active properties and can therefore be used diversely as industrial auxiliaries and additives, for example as surfactants, emulsifiers, stabilizers, emollients or solubility promoters. In addition, these compounds where DS = 4 - 8 are suitable as low-calorie fat substitutes in foods. In the case of degrees of substitution (DS) of from 1 to 7, as a result of reaction with, for example, MA, mixtures of substances are obtained, where predominantly the 3 primary OH groups react. Under specific conditions, the 2 OH group of the glucose can also be selectively acylated (FR 2670493), the yields being generally low, e.g. about 42% in the case of the selective enzymatic acylation of the 1'-OH group using vinyl methacrylate and subtilisin in DMF (Chan, A.W.Y. & Ganem, B., Biocatalysis, 1993, 8, 163-169). Generally, there is a decreasing reactivity in the order HO-6 approx. = HO-6' > HO-1' > HO-2 approx. = HO-3'. Compounds where DS=2 and DS=3, accordingly, have predominantly the constitution shown in Fig. 4. 40 WO 99/48901 PCT/EP99/01619 11 The addition of the alkylamine R 2NH2 to the sucrose maleate or to mixtures of intermediates which can comprise up to 8 radicals R generally takes place stoichiometrically until complete reaction of the maleate CC double bond with a certain amine R 1 NH2. The amine R NH2 can, however, also be used in a substoichiometric amount, with retention of unsaturated maleate partial structures, for example in order to achieve a certain solubility of the products in water. Furthermore, it is also possible to use a mixture of two or more different alkylamines. Accordingly, the compounds according to the invention can also carry different radicals. The hydrophilicity to hydrophobicity ratio, which determines the surface-active properties of the compounds according to the invention, is adjusted by the structure of the alkyl substituents R2 and their degree of substitution (DS). The DS can be adjusted via the molar ratio of the alkylamine R 2NH2 to the sucrose. The solubility of the compounds according to the invention in water can, if desired, also be adjusted via additional sulfonate groups, in that a higher number of N-alkylaspartate radicals can be compensated by, preferably, to two sulfonate groups. The compounds according to the invention have in total up to eight radicals R , the DS being between 1 and 8. As the DS increases, the lipophilicity of the compounds in principle increases, and their solubility in water decreases correspondingly sharply. At the same time, this effect can again be compensated by the carboxylate or sulfonate groups introduced. As already explained, the amphoteric character and the solubility of the surface-active substances in water can thus be modulated in a simple manner, which is important for the intended fields of use. Thus, for cosmetic applications, e.g. in shampoos or bath preparations, but also in household cleaners, such as, for example, in dishwashing detergents, good foaming ability and good foam stability are of importance. The amphoteric character of the compounds suggests a particular tolerability by the skin and a skin-protection action, in that a favorable interaction with the collagen of the skin can occur. In this connection, the formation of a protective layer can be reduced the excessive attack of surfactants on the upper layers of the skin and their strong degreasing and irritancy as a result of other anionic surfactants present in a formulation. Furthermore, the hydrophilic carboxylate groups of the asparagine partial structure or K9 WO 99/48901 PCT/EP99/01619 12 optionally additional sulfonate groups ensure good wash-off from the skin, which is of particular importance for body cleansing. For surface-active substances, surfactants and emulsifiers, the DS is therefore preferably about 1-3, in particular 3, and for low-calorie fat replacements for foods preferably about > 3, in particular about 4-8. In the case of low-calorie fat replacements, melting points and taste sensations 2 can be controlled by the composition of the radicals R and the DS value: for example, only those fatty substances whose melting point is above body temperature and which are not liquid at room temperature produce a pleasant taste sensation. A tailored taste sensation, for example for a cocoa butter substitute, can be achieved by appropriate mixture of fatty amines of varying chain lengths, by using a C-12 (lauryl-), C-16 (palmityl-), C-10 (caprinyl-), C-14 (myristyl-) and C-18 (stearyl-)amines in matched ratios. The present invention therefore further provides for the use of a sucrose N alkylaspartate according to the invention as surface-active compounds, in particular the use of one or more sucrose-N-alkylaspartates according to the invention as additives in hygiene compositions, cleaners, cosmetics, foods and/or medicaments, or in pesticides or for the prevention and/or control of contaminations of water by chemicals and/or oil, for example as additive in soaps, scouring agents, all-purpose cleaners, dishwashing detergents, laundry detergents, shampoos, universal detergents and/or bath preparations, where the degree of substitution DS of at least one sucrose N-alkylaspartate is preferably between 1 and about 4. In a particular embodiment, the sucrose-N-alkylaspartate is used together with at least one other surface-active substance (cosurfactant), the cosurfactant is preferably chosen from alkyl polyglycosides, 6-0-monoester alkyl glycosides, alcohol ether sulfates or alkyl glucamides. The present invention further relates to the use of a sucrose N alkylaspartate according to the invention as low-calorie fat replacement, where the degree of substitution DS of at least one sucrose N alkylaspartate is preferably between about 4 and 8. RA4 WO 99/48901 PCT/EP99/01619 13 In another subject-matter of the present invention, the sucrose N alkylaspartate according to the invention is in the form of an aqueous solution, an emulsion, a suspension, a gel, a cream, a paste or a powder. The surface-active properties of the compounds according to the invention thus open up a large number of use possibilities. The use examples below serve to illustrate the diverse possible fields of use and do not signify a limitation on these examples. In the case of washing and cleaning, the reduction in surface tension brings about easier soil detachment from the fibers and stabilization of the soil constituents in the wash liquor. In the textile industry, the wash, dyeing and finishing operations are improved and accelerated with the help of surfactants. During wool dyeing, for example, the pore damage caused by the dyeing process is reduced, the surfactants have a stabilizing action in hydrogen peroxide bleaching baths, and the dispersion effect for textile dyes facilitates the dyeing process. In the leather industry, during the preparation of the hide, and in the paper industry, surfactants are important auxiliaries. They are added to car and engine oils to form uniform, non breaking lubricating films. In paints and surface coating they improve the wetting and, as a result of their dispersing action, also delay the settling out of the color pigments whilst the paints are standing. In cosmetics, in the food industry, in medicine, in disinfectants and in the case of pest control, the distribution of the active ingredients in a liquid phase or its adhesion to a surface is achieved. They can also be used as emulsifiers for bakery goods and ice cream. Floor treatments, furniture and car polishes, and paint strippers typically likewise comprise surfactants. During the recovery of ores, coal and potash, the solid substances are slurried by the surfactant coupling them to air bubbles (flotation). On the other hand, other surfactants can be influenced in their foaming ability as a result of the action of the surface-active substances, in that the ascension and bursting of the gas bubbles is promoted (defoaming). Such foam-control agents are used in particular in the case of dishwashing detergents and in many industrial processes, such as the production of paper and sugar. The low toxicity and biocompatibility known of other sugar radicals and of biosurfactants means that the compounds according to the invention also have similarly favorable properties. These advantages can, for example, ( also be utilized for fighting tanker accidents at sea and, generally, for WO 99/48901 PCT/EP99/01619 14 fighting oil contamination in water, in that the oil is more rapidly dispersed, without the disadvantages of an additional burden on rivers and lakes occurring as a result of the aid. In the pharmaceutical sector, biocompatible surfactants are used, for example, as auxiliaries in the preparation of vaccines, more specifically for the isolation of purification of bacterial polysaccharides as vaccines (see e.g. W097/30171). Depending on the intended use, in detergents, surfactants constitute about 10-40% of the total amount. The typical composition of a universal detergent can comprise e.g. 5-15% of a compound according to the invention, 3-5% of another foam regulator (soap or silicone oil), 30-40% of a builder (e.g. zeolite, polycarboxylate), 20-30% of a bleach (e.g. sodium perborate), 0-10% of an extender (e.g. sodium sulfate), 1.5-4% of a bleach activator (e.g. tetraacetylethylenediamine), 0.2-2% of a stabilizer for perborate (e.g. EDTA, Mg silicate), 0.3-1% of an enzyme (e.g. a protease), 0.5-1% of an antiredeposition agent (e.g. carboxymethylcellulose), 0.1 0.3% of an optical brightener (e.g. a stillbene or pyrazoline derivative) and 0.1-0.2% of a fragrance. The invention relates in particular to aqueous solutions, soaps, cleaners, such as scouring agents, all-purpose cleaners, dishwashing detergents or laundry detergents, shampoos, universal detergents, bath preparations, foods, cosmetics, emulsions, suspensions, jellies, face cleansers, cold wave and fixing compositions, surfactant preparations for babies, creams, pastes and powders which comprise at least one of the compounds according to the invention or else mixtures thereof with other surface-active substances (cosurfactants), for example alkyl polyglycosides (APGs), 6-0 monoester alkyl glycosides (Biosurf@ grades from Novo Nordisk), alcohol ether sulfates (AEs), or alkylglucamides. The betaine structure of the N-alkylaspartate given above in the compounds according to the invention is structurally very similar to the aspartic acid which occurs naturally in proteins. It is therefore to be assumed that the tendency, discussed e.g. in the case of purely nonionic RA4/ amphiphilic compounds, such as the N-alkylglucamines, towards the formation of carcinogenic N-nitrosamines does not exist.
WO 99/48901 PCT/EP99/01619 15 In the pharmaceutical industry, surface-active compounds are used in formulations for active ingredients, with which improved active-ingredient uptake is said to be achieved (drug delivery systems). Cyclosporin, for example, is formulated as a "microemulsion preconcentrate". Also in the case of vitamins, such as vitamins A and K, there are solubilizing formulations in micellar form. However, there are only very few suitable surface-active substances which on the one hand have a good capacity for the sufficiently stable inclusion of active ingredients, and which on the other hand have zwitterionic properties at a low critical micell concentration, and have low toxicity. In particular, the ability to form stable vesicles is desirable. For this, surface-active substances with short hydrophilic head groups and with long hydrophobic chains are required, as are present, for example, in the phosphatidylcholines. Similarly to the substances, the compounds according to the invention, having, for example, 2 long alkane chains (DS about 2), have structural prerequisites for the formation of stable vesicles. For example, mixing 4 g of a 2 compound according to the invention where DS = 2 and R = dodecyl in a liter of water gives a homogeneous, opaquely milky phase which remains stable and unchanged at pH 5-7 over 8 weeks. The observed light scattering is presumably caused by microvesicles, for which a minimal structure section is illustrated, for example, in Fig. 5. Alternatively, it is also possible to formulate larger structures according to the scheme K1-S1'-S2-K2-S2'-S3-K3-S3' etc., where K1 is "head group molecule 1", S1 is "tail group molecule 1", S1' is "a further tail group of molecule 1" etc. It is possible to incorporate pharmaceutical or cosmetic active ingredients into such vesicles which can lead to an improved presentation of the active ingredients. Suitable active ingredients are also therapeutic genes, antisense oligonucleotides or retroviral expression vectors, for whose application so-called transfection reagents are required. As a rule, lipids, such as, for example, DOTAP or DC cholesterol (SIGMA, Saint Louis, MO) are used for this purpose, or mixtures of neutral and cationic lipids. The cationic structural element promotes the complexation of the DNA, and the lipid fraction promotes integration into the cell membrane. These structural prerequisites also relate to the compounds according to the invention, which, as amino acids, can be in the WO 99/48901 PCT/EP99/01619 16 physiologically protonated form. In particular, the compounds according to the invention can therefore be used for the invitro or invivo transfection of cells, in particular skin cells, in order, for example, to heal genetic skin disorders. The transfection of skin cells with retroviral expression vectors is described, for example, in Deng., H. et al., Nature Biotechnology, 1997, Vol. 15, 1388-1391. The present invention thus further provides for the use of the sucrose N alkylaspartate according to the invention as transfection reagent. The compounds according to the invention can be used in a variety of application forms (formulations), for example in the food, medicament or hygiene sector. The application form is adapted to the respective field of application. The figures and examples below serve to illustrate the invention in more detail without limiting it: Description of the figures Fig. 1 shows diagrammatically the preparation of the sucrose N alkylaspartates according to the invention and the calculation of the degree of substitution DS. Fig. 2 shows known sucrose fatty acid esters. Fig. 3 shows a maleate half-ester of sucrose. Fig. 4 shows examples of compounds where DS = 2 and DS = 3. Further maleate groups, of which up to 6 can be present if DS = 2 and up to 7 can be present if DS = 3, and also sulfonate groups, of which, preferably, up to 2 groups can be present, are not shown in the formulae. The exact position of the substituents can vary and deviate from the representation shown here. Fig. 5 shows a minimum structural section of a microvesicle. Fig. 6 shows, in graph form, the results of comparative experiments relating to foam stability. Fig. 7 shows, in graph form, the results of comparative experiments relating to the dispersing action.
~RA
4 / N) - WO 99/48901 PCT/EP99/01619 17 EXAMPLES Example 1: Synthesis using sodium acetate in DMF: DS = 2.0, R 2 dodecyl, 30.0 g (87.6 mmol) of sucrose, 15.8 g (192.6 mmol, 2.2 equiv.) of sodium acetate and 18.9 g (192.8 mmol, 2.2 equiv.) of maleic anhydride were stirred in 150 ml of dry N,N-dimethylformamide at 50 0 C for 3 hours. According to the thin layer chromatogram, all of the sucrose had then reacted. 35.7 g (193 mmol, 2.2 equiv.) of 1-dodecylamine (laurylamine) were added, and the mixture was stirred for a further 3 hours at 50 0 C. During the reaction, some of the product precipitated out as a colorless solid. Most of the solvent was distilled off under reduced pressure, and replaced by ethyl acetate, with stirring. The product was filtered off, washed with ethyl acetate and dried under reduced pressure at 70 0 C. Yield: 83.9 g. Based on a composition where DS=2 of the empirical formula
C
44
H
78 Na2N2O17 (953 g/mol), the yield was 100%. The H-NMR assignment (in CDCl3/CD 3 OD) gave a DS of about 2.0: 8 = 1.85 (t, Me), 1.25 (m, CgH18), 2.6-3.3 (m, CH 2 NCHCH2), 2.30-5.40 (sucrose CHO). [Assignment compared with the N-dodecylaspartate C1 2
H
25 NHCH(COONa)CH2COOCH3; as a result of the micell or vesicle formation, line broadenings and deviating shifts occurred, e.g. CH2COO sucrose can also be assigned to the broad multiplett at 8 = 1.95. In the case of the N-dodecylaspartate C1 2
H
25 NHCH(COONa)CH2COOCH3, the corresponding CH2 signal is at 8 = 2.4 (CDCl 3 ).] Elemental analysis: N (found) 2.7%, (N calculated for DS = 2.0: 2.9%), Na (found) 4.2% (Na calculated for DS = 2.0: 4.8%). Mass spectrum (electrospray, ESI-MS): [M1-H+}- = 624 (Ml = C 28
H
5 1NO14; 625); [M2]- = 908 (M2 = C44H 8 0N2017; 908); [(Ml-2H++Na+)2]- = 1272; in the positive mode: [M+H+]+ = 626 (Mi = C2 8 H51NO14; 625); [M 1 +Na+]+ = 648; [M2+H+]+ = 907; [(Ml+H+)2]+ = 1252. Example 2: Synthesis using sodium carbonate in DMF: DS = 2.1, R2 = dodecyl 30.0 g (87.6 mmol) of sucrose, 10.2 g (96.2 mmol, 2.2 equiv. of Na ) of sodium carbonate and 18.9 g (192.8 mmol, 2.2 equiv.) of maleic anhydride WO 99/48901 PCT/EP99/01619 18 were reacted for 2 hours at 800C and then for a further 3 hours at 1000C in 150 ml of dry N,N-dimethylformamide with stirring. According to the thin layer chromatogram, the sucrose had then completely reacted. 37.6 g (203 mmol, 2.32 equiv.) of 1-dodecylamine were added, and the mixture was stirred for a further 3 hours at 500C and for a further 2 hours at 700C. During the reaction, some of the product precipitated out as a colorless solid. Most of the solvent was distilled off under reduced pressure, and replaced by ethyl acetate, with stirring. The product was filtered off as colorless solid, washed with ethyl acetate and dried under reduced pressure at 700C. Yield: 82.9 g (96% based on product where DS = 2.1
(C
45
-
6
H
8 0
-
8 Na2.1N2.1017.3 = 983.6 g/mol). H-NMR (CDC1 3
/CD
3 0D) gave a DS = 1.9-2.2 (assignment see Example 1). Elemental analysis: N (found) 2.7%, N (calculated for DS = 2.1: 3.0%) Na (found) 4.8%, Na (calculated for DS = 2.0: 4.9%). Mass spectrum (electrospray, ESI-MS): [M1-H+]~ = 624 (Mi = C 28
H
5 1NO14; 625); [M2-H+]~ = 907 (M2 = C 4 4H 8 0N2017; 908); [2M 1 -H+] = 1249; [2M1+Na+-2H+}- = 1271; in the positive mode: [M+H+]+ = 626 (Mi = C 28
H
5 1NO14; 625); [M1+Na+]+ = 648; [M2+H+]+ = 907;
[(M
1
+H+)
2 }] = 1252. Example 3: Synthesis using sodium carbonate in DMSO: DS = 1.9, R 2 dodecyl 30.0 g (87.6 mmol) of sucrose, 5.1 g (48.1 mmol, 1.1 equiv. of Na+) of sodium carbonate and 9.5 g (96.9 mmol, 1.1 equiv.) of maleic anhydride were reacted for 2 hours at 300 in 100 ml of dry DMSO with stirring. After the addition of a further 5.1 g (48.1 mmol, 1.1 equiv. Of Na+) of sodium carbonate and 9.5 g (96.9 mmol, 1.1 equiv.) of maleic anhydride, the mixture was stirred for a further 8 hours at 300 and a further 2 hours at 600C. According to the thin layer chromatogram, all of the sucrose had then reacted. 35.7 g (193 mmol, 2.2 equiv.) of 1-dodecylamine were added, and the mixture was stirred for 3 hours at 300C and for 2 hours at 400C. During the reaction, some of the product precipitated out as a colorless solid. Most of the solvent was distilled off under reduced pressure, and replaced by ethyl acetate with stirring. The product was filtered off as a colorless solid, washed with ethyl acetate and dried under reduced pressure at 700C. Yield: 75.4 g (93% for DS = 1.9). -7' WO 99/48901 PCT/EP99/01619 19 2 Example 4 Synthesis using sodium acetate in DMSO: DS = 2.2, R = dodecyl 30.0 g (87.6 mmol) of sucrose, 15.8 g (192.6 mmol, 2.2 equiv.) of sodium acetate and 18.9 g (192.8 mmol, 2.2 equiv.) of maleic anhydride were reacted for 2 hours at 50*C in 100 ml of dry dimethyl sulfoxide with stirring. According to the thin layer chromatogram, all of the sucrose had then reacted. 35.7 g (193 mmol, 2.2 equiv.) of 1-dodecylamine (laurylamine) were added, and the mixture was stirred for a further 3 hours at 50 0 C and for a further 2 hours at 70*C. During the reaction, some of the product precipitated out as a colorless solid. Most of the solvent was distilled off under reduced pressure, and replaced by ethyl acetate with stirring. The product was filtered off as a colorless solid, washed with ethyl acetate and dried under reduced pressure at 70*C. Yield: 81.5 g (92% for DS = 2.2). The DS was determined by means of integration of the 1 H-NMR spectrum from the ratio of the sucrose CHO signals and the N-dodecylaspartate signals. Example 5: Synthesis using sodium acetate in DMSO: DS = 1.0, R 2 dodecyl 30.0 g (87.6 mmol) of sucrose, 15.8 g (192.6 mmol, 2.2 equiv.) of sodium acetate and 18.9 g (192.8 mmol, 2.2 equiv.) of maleic anhydride were reacted for 2 hours at 500C in 100 ml of dry dimethyl sulfoxide with stirring. According to the thin layer chromatogram, the sucrose had then completely reacted. 17.9 g (96.4 mmol, 1.1 equiv.) of 1-dodecylamine were added, and the mixture was stirred for a further 6 hours at 200C. Most of the solvent was distilled off under reduced pressure, and replaced by ethyl acetate with stirring. The product was filtered off as a colorless solid, washed with ethyl acetate and dried under reduced pressure at 700C. Yield: 66.3 g (98.6%). The DS was determined by means of integration of the 1 H-NMR spectrum from the ratio of the CHO, maleate and N-dodecyl signals as about 1.0 (C 28
H
5 0NaNO14 = 647.7 g/mol). Example 6: S nthesis using sodium carbonate in DMSO and coconut fatty amine C 1 2: R = dodecyl WO 99/48901 PCT/EP99/01619 20 30.0 g (87.6 mmol) of sucrose, 10.2 g (96.4 mmol) of sodium carbonate and 18.9 g (192.8 mmol, 2.2 equiv.) of maleic anhydride were reacted for 3 hours at 500C in 100 ml of dry dimethyl sulfoxide with stirring. According to the thin layer chromatogram, the sucrose had then completely reacted. 40.0 g of Genamin@ 12R1OOD [from coconut fat, average empirical formula CH 3 (CH2)12.3 NH2] were added, and the mixture was stirred for a further 3 hours at 40 0 C. During the reaction, some of the product precipitated out as a colorless solid. Most of the solvent was distilled off under reduced pressure, and replaced by ethyl acetate with stirring. The product was filtered off as a colorless solid, washed with ethyl acetate and dried under reduced pressure at 70 0 C. Yield: 78.0 g (89% for DS = 2.2). Example 7: Synthesis using sodium acetate in DMF: DS = 8, R2 = dodecyl 10.0 g (29.2 mmol) of sucrose, 21.6 g (263 mmol, 9 equiv.) of sodium acetate and 25.8 g (263 mmol) of maleic anhydride were stirred for 3 hours at 400C in 150 ml of dry N,N-dimethylformamide. The 1 H-NMR analysis of a sample in D20 shows only small amounts of maleic anhydride (6 = 6.30 ppm) and the formation of the oleofinic maleate protons at 6 = 6.70 ppm and 8 = 5.90 ppm in the expected integration ratio. 48.7 g (263 mmol, 9 equiv.) of 1-dodecylamine were added, and the mixture was stirred for 14 h at 200C. Most of the solvent was distilled off under reduced pressure, and replaced by ethyl acetate with stirring. The product was filtered off, washed with ethyl acetate and dried under reduced pressure at 700C. Yield: 73.0 g (96%). Example 8: Synthesis using sodium acetate in DMF: DS = 8, R 2 dodecyl/hexadecyl/octadecyl (35/60/5%) 10.0 g (29.2 mmol) of sucrose, 21.6 g (263 mmol, 9 equiv.) of sodium acetate and 25.8 g (263 mmol) of maleic anhydride were dried for 3 hours at 400C in 150 ml of dry N,N-dimethylformamide. A mixture comprising 17.1 g (92.0 mmol) of 1-dodecylamine, 38.1 g (157.8 mmol) of 1-hexadecylamine and 3.5 g (13.1 mmol) of 1-octadecylamine was added, and the mixture was stirred for 14 h at 200C. Most of the solvent was distilled off under reduced pressure, and replaced by ethyl acetate with stirring. The product was filtered off, washed with ethyl acetate and dried under reduced pressure at 700C. Yield: 90.0 g. (99%).
WO 99/48901 PCT/EP99/01619 21 Example 9: Synthesis of (1) without the use of solvent 30.0 g (87.6 mmol) of sucrose, 15.8 g (192.6 mmol, 2.2 equiv.) of sodium acetate were stirred for 20 minutes at a bath temperature of 195 0 C under reduced pressure (about 20 torr). The mixture was cooled to 175 0 C (bath temperature) at atmospheric pressure, and 18.9 g (192.8 mmol, 2.2 equiv.) of molten maleic anhydride were slowly added dropwise thereto (5 minutes). The mixture turned brown, started to foam, and was cooled after 2 minutes to 125 0 C with stirring. 1 H-NMR analysis of a sample in D20 revealed only small amounts of maleic anhydride (8 = 6.30 ppm) and the formation of the oleofinic maleate protons at 8 = 6.70 ppm and 8 = 5.90 ppm in the expected integration ratio. 35.7 g (193 mmol, 2.2 equiv.) of 1-dodecylamine (laurylamine) were added, the mixture was stirred for 20 minutes at 1250C, and then ethyl acetate was added with evaporative cooling and stirring. The product was filtered off, washed with ethyl acetate and dried under reduced pressure at 700C. Example 10: Monosulfonation using chlorosulfonic acid 5.0 g (6.0 mmol) of the product from Example 1 (RS 786) were suspended in 50 ml of dichloromethane and 1 ml of dimethylsulfoxide. Over the course of 1 hour, 0.4 ml (6.0 mmol) of chlorosolfonic acid in 25 ml of dichloromethane were added dropwise at room temperature. The mixture was stirred for a further 3 hours at room temperature, to give a clear solution. The solvent was stripped off under reduced pressure. The product was then washed by stirring with ethyl acetate, filtered off with suction and dried under reduced pressure at 600C. This gave 4.6 g of a colorless solid (RS 814). Example 11: Monosulfonation using pyridine-S03 complex 5.0 g (6.0 mmol) of the product from Example 1 (RS 786) were stirred into 50 ml of dimethylformamide at 700C until virtually all of the solid had dissolved. The mixture was then left to cool to 300C, and 1.0 g of sulfur trioxide-pyridine-complex were added. The mixture was stirred for 3 hours at 300C and for 1 hour at 600C. The solvent was stripped off under reduced pressure. The product was then washed by stirring with ethyl C 111 WO 99/48901 PCT/EP99/01619 22 acetate, filtered off with suction and dried under reduced pressure at 60 0 C. This gave 4.3 g of a colorless solid (RS 825). Example 12: Determination of the surface tension The compounds according to the invention, in particular those having a degree of acylation up to DS = 3, had excellent surface-active properties. Table 1 shows that the compounds according to the invention reduce the surface tension of water. The critical micell concentration (CMC) and the lowering of the surface tension (amin) were measured using a tensiometer (Lauda, model TD1, water double-distilled, amin = 71.8 mN/m) at 25 0 C. For this, the concentration was increased up to the minimum force to be applied in order to obtain the CMC and amin values. Product from Example 1: C44H78Na2O17 = 953 g/mol (RS 786) Product from Example 5: C28H50NaNO14 = 647.7 g/mol (RS 795) Product from Example 10: (RS 814): C44H78Na2N2O20S = 1033 g/mol Table 1: CMC and amin values CMIC [mol/l] [mN/mL
C
12
H
25 NaSO4 8.6 x 10-3 37.4 (SDS) RS 786 1.0 X 10~ 29.7 RS 795 4
.
3 x 10~4 36.5 RS 814 1.4 x 10-3 21.2 The results in Table 1 illustrate the very good surfactant properties of the compounds (1) according to the invention, which, for example, are superior to a commercially used standard surfactant (SDS). Example 13: Measurement of the foam height and foam stability In certain fields of application, e.g. for dishwashing detergents, high foaming surfactants are required. Data on the foaming properties is obtained, for example, according to the Ross Miles method (ASTM D1 173 53, Oil & Soap 62, 1260, 1958). According to this, 200 ml of the surfactant .' R solution are run in, via a pipette having an internal diameter of 2.9 mm, ver a 90 cm drop, into a measuring cylinder containing 50 ml of the same WO 99/48901 PCT/EP99/01619 23 surfactant solution. The foam height was read off immediately (t = 0, IFH = initial foam height) and then at given points in time. Using this experimental arrangement, the foam heights at 25 0 C and using a 0.1% concentration of the novel product in question from Example 1: RS 786; product from Example 5: RS 795 were [lacuna]. Surprisingly, the substance RS 795, which was still clearly soluble up to 20 g/l, showed, after a slight drop in foam height within the first 5 minutes, virtually no further drop over a period up to 2 hours. Even the less readily soluble substance RS 786, which can dissolve clearly in water only up to 4 g/l, showed, after an initial drop, excellent foam stability. By contrast, the foam of SDS disappeared virtually completely within about 100 minutes (see Fig. 6). The foam stability of the sulfonate prepared as in Example 10 was likewise excellent: the foam height dropped here from 33 mm (product from Example 10) to 24 mm over the course of 2 hours in the same test procedure. Example 14: Dispersing action To determine the solubilization of Sudan Red B in water using the compounds according to the invention, 12.5 mg of Sudan Red B were added in each case to solutions of varying concentrations (0.075 g, 0.150 g and 0.300 g in 25 ml of water). The dye was dispersed using ultrasound. The suspension was then centrifuged at 7500 rpm for 70 min and filtered through a membrane. The absorbance of the supernatant clear solution was measured photometrically at a wavelength of 516 nm (cell length 1 cm). The blank used was the solution of Sudan Red B in water (12.5 mg in 25 ml). The compound named "caprylate" is a caprylate of the oxidized sucrose from Example 10 in DE 19542303. This comparison compound is accordingly significantly less effective than, for example, the compound from Example 1. The same applies in the case of low concentrations up to 0.3% by weight to the less substituted compound from Example 5 (see Tab. 2, Fig. 7). Tab. 2 UV absorbance Conc. Caprylate* 1 1 (% by wt.) (Example 1 (Example 5 1_= RS 783 =RS 795 0.0 0.0001 0.0002 0.0001 0.3 0.0096 0.0495 0.0253 WO 99/48901 PCT/EP99/01619 24 0.6 0.0654 0.0997 0.0571 1.2 0.1513 0.1603 0.1003 These measured results show that the compounds according to the invention have excellent solubilizing properties. The compounds are therefore suitable, for example, for laundry detergents, dishwashing detergents and cleaners, and as formulation auxiliaries in the pharmaceutical sector and in the agricultural sector. Example 15: Solubilization of an active ingredient Pharmaceutical active ingredients and food additives for which no suitable presentation is obtainable can be better solubilized in water or incorporated into other formulations. Obvious examples for improving effectiveness are, for example, Doxorubicin (tumor therapy), Amphotericin (treatment of mycoses) and vitamins (additive). In the present example, 50 mg of vitamin E (tocopherol) were smoothly absorbed by only 150 mg of compound from Example 1 without the addition of solvent (see Tab. 3). A dispersion experiment in water (25 ml) was carried out analogously, as described in Example 14: Tab. 3 Vitamin E Comp. 1 UV (mg) (mg) absorbance (290 nm) 12.5 0 0.0115 12.5 75 0.6997 12.5 150 0.9005 12.5 300 0.9819 Example 16: Preparation of active ingredient formulations for crop protection agents and for the treatment of seed Fungicides and insecticides which are sparingly soluble in water in foliar sprays or in seed dressing treatments can be better formulated using additives of the compounds according to the invention. A typical 441 WO 99/48901 PCT/EP99/01619 25 formulation is, for example, prepared from 20-600 g of a fungicide or 10 500 g of an insecticide, 50-150 g of a frost-protection agent, such as ethylene glycol or propylene glycol, 2-10 g of an antifoam, 2-100 g of a compound according to the invention and water (to top up to give a 1 liter formulation). Example 17: Hand washing experiment on healthy and on sensitive/diseased skin 2 g of the product from Example 2 form, at 200C in 100 ml of water, a colorless, finely-pored-foaming emulsion of PH about 9. This emulsion was adjusted, using citric acid, to the physiological PH of healthy skin, which is about 5.5. Handwashing experiments using this solution gave, on healthy and also on stressed skin, sensitive skin and skin suffering from chronic dermatosis, a subjectively pleasant, irritation-free feel on the skin, and an excellent cleansing effect. A comparable treatment with conventional soap lead in the case of the test persons to a itchy skin reddening within about 5 minutes, which then had to be treated with a corticosteroid ointment. The formulations comprising compounds according to the invention are therefore suitable particularly for frequent washing, showering and bathing in cases of sensitive or diseased skin, and also for the cleansing, in particular, of teenager's skin. The subjectively mild character evidently imparts an effect to the compounds which stabilizes the protective acid mantel of the skin. Example 18: Preparation of a shampoo To prepare 1 kg of a shampoo, 60 g of the compound according to the invention (e.g. from Example 1), 130 g of cocamidopropylbetaine, 15 g of NaCl, 1.5 g of preservative (e.g. potassium sorbate and/or sodium benzoate), 0.5 g of allantoin, 2 g of sodium formate, 7 g of sodium citrate and 1 g of perfume oil are mixed and made up to 1 kg with water. This gives a skin-and hair-compatible, highly effective shampoo. Example 19: Preparation of a scouring agent To prepare 1 kg of a scouring agent, 30 g of the compound according to the invention (e.g. from Example 2), 20 g of octadecyl polyethylene glycol WO 99/48901 PCT/EP99/01619 26 ether, 45 g of pentasodium triphosphate and 2 g of fragrance are mixed and made up to 1 kg with quartz powder. Example 20: Preparation of a laundry detergent To prepare 1 kg of a laundry detergent, 150 g of the compounds according to the invention (e.g. from Example 3), 200 g of complexing agent, e.g. zeolite, 30 g of laundry detergent protease, 35 g of sodium citrate, 80 ml of ethanol and optionally fragrances and dyes are mixed and made up to 1 kg with water. Example 21: Preparation of a bath preparation To prepare 1 kg of a bath preparation, 20 g of the compound according to the invention, (e.g. from Example 3), 45 kg of coconut fatty acid ethanolamine, 50 g of almond oil, 10 g of sodium chloride, 3.5 g of preservative, 10 g of hexadecanol and 10 g of perfume are mixed and made up to 1 kg with water. Example 22: Testing the biodegradability According to OECD 301 B, substances can be classified as readily biodegradable if at least 60% of the carbon has been mineralized to carbon dioxide following contact with an activated sludge mixed population for 28 days. In this test, a compound according to the invention (sample from Example 1) had metabolized to 60.3% after just 18 days. The substance is accordingly very readily biodegradable.
Claims (19)
1. A sucrose N-alkylaspartate of the formula (1) R 1 0 R 1 0O OR1, R 1 0 (I) RI in which R independently of one another, identically or different is a group chosen from hydrogen, a compound of the formula (II): 0 O Ol ' 0. M* HN-R 2 (11) where R2 is CnH2n+1 or CnH2n, in which n is an integer from 2 to 28, preferably 6-22, especially 12-18, a compound of the formula (Ill) O'ol M+ (111) and/or a radical of the formula (IV) WO 99/48901 PCT/EP99/01619 28 O=S-O M (IV) and M+ is hydrogen, an alkali metal ion and/or an alkaline earth metal ion, preferably a sodium, potassium, lithium, magnesium, calcium and/or ammonium ion, with the proviso that at least one radical R is a compound of the formula (II).
2. A sucrose N-alkylaspartate as claimed in claim 1, wherein the degree of substitution of the radical R (DS) is defined by the following formula: DS = n x [radical of the formula (11)] + [0 to (8-n)] x [radical of the formula (111)] + (0 to m) x [radical of the formula (IV)], where m = 2 when n = 1-6, and m = 1 when n = 7 and n 8.
3. A sucrose N-alkylaspartate as claimed in claim 1 or 2, wherein R2 is a decyl, dodecyl, tetradecyl, hexadecyl or octadecyl radical, or a radical derived from coconut, palm, soya or tallow oil fats, or mixtures thereof.
4. A process for the preparation of a sucrose N-alkylaspartate of the formula (1), which comprises, in a first step, acylating sucrose with maleic acid or a derivative of maleic acid, and, in a second step, adding one to eight mole equivalents of amine of the formula R NH2 where R2 is CnH2n+1 or CnH2n, in which n is an integer from 2 to 28, preferably 6-22, especially 12-18, to the maleate sucrose formed in the first step.
5. The process as claimed in claim 4, wherein the acylating reaction is carried out in the presence of a catalyst.
6. The process as claimed in claim 5, wherein the catalyst is a basic metal salt, preferably a carbonate, hydrocarbonate, acetate and/or formate. WO 99/48901 PCT/EP99/01619 29
7. The process as claimed in one of claims 4-6, wherein, in a further step, the resulting sucrose N-alkylaspartate is sulfonated.
8. The process as claimed in claim 7, wherein up to two radicals R are sulfonated.
9. The process as claimed in claim 7 or 8, wherein the sulfonation is carried out with S03, CISO3H, DMF-S03 and/or pyridine-S03.
10. The use of a sucrose N-alkylaspartate as claimed in one of claims 1-3 as surface-active compound.
11. The use of one or more sucrose N-alkylaspartates as claimed in one of claims 1-3 as additive in hygiene compositions, cleaners, cosmetics, foods and/or medicaments or in pesticides or for the prevention and/or control of contamination of water by chemicals and/or oil.
12. The use as claimed in claim 11 as additive in soaps, scouring agents, all-purpose cleaners, dishwashing detergents, laundry detergents, shampoos, universal detergents and/or bath preparations.
13. The use as claimed in claim 11 or 12, wherein the degree of substitution DS of at least one sucrose N-alkylaspartate is between 1 and about 4.
14. The use as claimed in one of claims 10-13, wherein the sucrose N alkylaspartate is used together with at least one other surface-active substance (cosurfactant).
15. The use as claimed in claim 14, wherein the cosurfactant is chosen from alkyl polyglycosides, 6-0-monoester alkyl glycosides, alcohol ether sulfates or alkyl glucamides.
16. The use of a sucrose N-alkylaspartate as claimed in one of claims 1-3 as low-calorie fat substitute. WO 99/48901 PCT/EP99/01619 30
17. The use as claimed in claim 16, wherein the degree of substitution DS of at least one sucrose N-alkylaspartate is between about 4 and 8.
18. The use of a sucrose N-alkylaspartate as claimed in one of claims 1-3 as transfection reagent.
19. A sucrose N-alkylaspartate as claimed in one of claims 1-3 in the form of an aqueous solution, emulsion, suspension, gel, cream, paste or powder.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19812661A DE19812661A1 (en) | 1998-03-23 | 1998-03-23 | Sucrose-N-alkyl asparaginates, their preparation and use |
| DE19812661 | 1998-03-23 | ||
| PCT/EP1999/001619 WO1999048901A2 (en) | 1998-03-23 | 1999-03-12 | Sucrose-n-alkyl-asparaginates, production and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU3411399A true AU3411399A (en) | 1999-10-18 |
| AU746197B2 AU746197B2 (en) | 2002-04-18 |
Family
ID=7861956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU34113/99A Ceased AU746197B2 (en) | 1998-03-23 | 1999-03-12 | Sucrose-N-alkyl-asparaginates, production and use thereof |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1066305A2 (en) |
| JP (1) | JP2002507621A (en) |
| AU (1) | AU746197B2 (en) |
| CA (1) | CA2325396A1 (en) |
| DE (1) | DE19812661A1 (en) |
| WO (1) | WO1999048901A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020257749A1 (en) | 2019-06-21 | 2020-12-24 | Ecolab Usa Inc. | Solid nonionic surfactant compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS49116104A (en) * | 1973-03-12 | 1974-11-06 | ||
| DE2739343A1 (en) * | 1977-09-01 | 1979-03-15 | Bayer Ag | BASIC ESTERS OF POLYHYDROXYL COMPOUNDS |
| FR2670493A1 (en) * | 1990-12-13 | 1992-06-19 | Isochem Sa | New sucrose monoester compounds such as 2-O-acylsucroses and 6-O-acylsucroses, as well as processes for their synthesis |
| SE9401826D0 (en) * | 1994-05-27 | 1994-05-27 | Pharmacia Ab | Anti-Helicobacter pyroli substance |
| DE19542303C2 (en) * | 1995-11-14 | 1998-03-26 | Suedzucker Ag | Acylated sucrose monocarboxylic acids |
-
1998
- 1998-03-23 DE DE19812661A patent/DE19812661A1/en not_active Withdrawn
-
1999
- 1999-03-12 EP EP99915582A patent/EP1066305A2/en not_active Withdrawn
- 1999-03-12 WO PCT/EP1999/001619 patent/WO1999048901A2/en not_active Ceased
- 1999-03-12 JP JP2000537884A patent/JP2002507621A/en active Pending
- 1999-03-12 AU AU34113/99A patent/AU746197B2/en not_active Ceased
- 1999-03-12 CA CA002325396A patent/CA2325396A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999048901A2 (en) | 1999-09-30 |
| AU746197B2 (en) | 2002-04-18 |
| JP2002507621A (en) | 2002-03-12 |
| EP1066305A2 (en) | 2001-01-10 |
| DE19812661A1 (en) | 2000-09-28 |
| WO1999048901A3 (en) | 1999-11-11 |
| CA2325396A1 (en) | 1999-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11760889B2 (en) | Unsaturated fatty alcohol derivatives from natural oil metathesis | |
| US5433894A (en) | Compositions comprising fatty acid esters of alkoxylated isethionic acid & process for making | |
| US5580850A (en) | Foaming detergent mixtures | |
| US4376789A (en) | Surfactants which are polyhydric alcohol partial esters of adducts of maleic anhydride with an unsaturated carboxylic acid | |
| US5663137A (en) | Ultramild surfactant mixtures II | |
| EP0670844B1 (en) | Aldonamides and their use as surfactants | |
| EP0510565A1 (en) | Surface-active agents derived from sulfosuccinic esters | |
| JP4020961B2 (en) | Amphiphilic compounds having at least two hydrophilic groups and at least two hydrophobic groups based on diol ethers, oligool ethers or polyol ethers | |
| US5246695A (en) | Use of alkylglycoside sulfosuccinates for the production of cosmetic preparations and cleaning agents | |
| Behler et al. | Industrial Surfactant Syntheses and Gu¨ nter Uphues | |
| US6013616A (en) | Mild detergent mixtures | |
| AU746197B2 (en) | Sucrose-N-alkyl-asparaginates, production and use thereof | |
| US5190699A (en) | Citric acid fatty alcohol ester polyglycol ether sulfosuccinates, process for their preparation and their use | |
| US5658875A (en) | Ultramild surfactant mixtures | |
| CA1230558A (en) | Vegetable oil adducts as emollients in skin and hair care products | |
| US3891682A (en) | Acylamidoethoxyethyl sulfosuccinate salts, methods of producing the same and froth-forming compositions containing the same | |
| US5952279A (en) | Mild detergent mixtures | |
| US5371251A (en) | Polyol polyether sulfosuccinates, a process for preparing them, and their use | |
| JPH11501299A (en) | Amphiphilic compound having at least two hydrophilic groups and at least two hydrophobic groups having dicarboxylic acid diester as a basic structure | |
| CA2199067A1 (en) | Polyglycerin ester sulfosuccinates, method for their preparation, and their use | |
| US7285647B2 (en) | Fatty acid esters of ethoxylated alkylglucosides | |
| JP2006265104A (en) | Phospholipid derivatives for external preparation for skin, external preparation for skin, liposome and fat emulsion | |
| JPH083114B2 (en) | Detergent manufacturing method | |
| JPH10310788A (en) | Bisamide-type surfactant and detergent composition containing the same | |
| EP0771346A1 (en) | Detergent mixtures with improved washing power |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |